Actor James Van Der Beek has been so open, honest, and vulnerable about his journey with colorectal cancer after revealing ...

Q2 2025 Pre Recorded Earnings Conference Call August 7, 2025 2:00 AM ETCompany ParticipantsKhalid Waleed Hosny ...

Diagnostic imaging company RadNet (NASDAQ:RDNT) will be announcing earnings results next tomorrow after market close. Here’s ...

Cathie Wood’s ARK Invest ETFs (exchange-traded funds) made a $69 million bet on Exact Sciences ($EXAS) on August 7, marking the largest ...

Guardant Health earns the No. 12 rank among its peers in the Medical-Services industry group. GeneDx Holdings WGS, Hims & Hers Health HIMS and Stevanato Group STVN are among the top 5 highly rated ...

New research reveals that updated colorectal cancer screening among younger Americans has led to significant increases in local-stage tumor detection and diagnoses.

GUARDANT HEALTH INC (NASDAQ: GH) faced a significant sell-off, with ARK parting with 1,419,766 shares for a total of approximately $63.31 million. This trade marks a notable exit from the precision ...

Baron Capital’s Q2 report highlights biotech, surgical tech, and GLP-1 winners. Discover which health care stocks surged and ...

The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth ...

Exact Sciences has a multipronged approach to cancer testing. Its flagship product line is Cologuard, the market leader in stool-based screening for colorectal cancer, or CRC. Its second-largest ...

AppLovin reported second-quarter revenue of $1.26 billion, missing analyst estimates of $1.31 billion, according to Benzinga ...

James Van Der Beek is sharing the subtle colorectal cancer symptom he ignored before his shocking diagnosis. “There wasn’t ...